February 3, 2010
Pneumococcal Vaccination Recommended to Help Prevent Infections Secondary to H1N1 Influenza
Influenza predisposes individuals to developing bacterial community-acquired pneumonia. The Alliance Working for Antibiotic Resistance Education (AWARE), a project of the California Medical Association Foundation, supports the Centers for Disease Control and Prevention’s recommendations regarding pneumococcal vaccination. Pneumococcal infections have been identified as an important complication in severe and fatal cases of 2009 H1N1 influenza virus infection. For more information, please visit the Health Alert Network Info Service message.